WHO prequalifies first monoclonal antibody - tocilizumab – to treat COVID-19

Retrieved on: 2022-02-12 04:18:27

Tags for this article:

Medical specialties

Medicine

Health sciences

Immunosuppressants

Tocilizumab

Pharmaceutical industry

Click the tags to see associated articles and topics

WHO prequalifies first monoclonal antibody - tocilizumab – to treat COVID-19. View article details on HISWAI: https://www.who.int/news/item/11-02-2022-who-prequalifies-first-monoclonal-antibody---tocilizumab-to-treat-covid-19

Excerpt

Aiming to increase access to recommended treatments for COVID-19, WHO today added tocilizumab, a monoclonal antibody, to its list of prequalified ...

Article found on: www.who.int

View Original Article